aceQuantified enhancement volume based on MRI as a prognostic biomarker for early recurrence in hepatocellular carcinoma
To investigate the association between MRI multi-phase enhancement volume and early recurrence in patients with hepatocellular carcinoma (HCC). This multicenter retrospective study included 532 HCC patients who underwent hepatectomy and were divided into an internal cohort (n=372) and an external cohort (n=160). We automatically measured multi-phase enhanced volume on MRI using artificial intelligence techniques, including arterial phase enhancement volume fraction (AP_EnVF), portal venous phase enhancement volu…
An AI-measured arterial phase enhancement volume fraction on preoperative MRI was independently associated with early recurrence after liver cancer surgery, in both an internal and an external patient group.
Evidence
- Peer-reviewedBMC Medical Imaging2026-10-24
How should this claim be treated?
Truvace Impact Record TRV-2026-2264, v1: “Quantified enhancement volume based on MRI as a prognostic biomarker for early recurrence in hepatocellular carcinoma.” Truvace, 2026-10-26. /record/TRV-2026-2264 (accessed at citation time). sha256 86e334041a3e7f5f…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-2264 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.